Answer
In 12-month Ganfort clinical data, the most commonly reported adverse reaction was conjunctival hyperaemia, mostly trace to mild and thought non-inflammatory, affecting approximately 26% of patients and leading to discontinuation in 1.5%.
Sources for this answer
- GANFORTAbbVie Ltd · emc · SmPC §4.8 Undesirable effects · Version 15Document updated
Sources checked